Hyperbaric oxygen Safe with Limited Efficacy in Reducing severity of radiation-induced dermatitis: Study Dr. Shravani Dali2 May 2025 8:45 PM ISTResearchers have found in a pilot study that hyperbaric oxygen therapy (HBOT) did not significantly reduce the severity of radiation-induced...
Low-Dose Sirolimus as Effective as High-Dose for Kaposiform Hemangioendothelioma Treatment, suggests study Dr. Shravani Dali28 April 2025 8:45 PM ISTResearchers have found in new research that low-dose sirolimus is noninferior to high-dose sirolimus in the treatment of Kaposiform...
Selumetinib shows Limited Efficacy in Treatment of cutaneous neurofibromatosis: JAMA Dr. Shravani Dali12 March 2025 9:00 PM ISTResearchers have found in a nonrandomised pilot trial that selumetinib showed a reduction in cutaneous neurofibromatosis volume, but it did not lead...
Deucravacitinib Shows Consistent Efficacy in Psoriasis Treatment: Study Dr. Shravani Dali21 Feb 2025 8:30 PM ISTResearchers have found in a new study that deucravacitinib effectively reduces Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality...
Study Highlights Long-Term Efficacy of Ritlecitinib in Alopecia Areata Dr. Shravani Dali18 Feb 2025 8:45 PM ISTResearch suggests that ritlecitinib is effective for long-term treatment in patients with alopecia areata who have greater than or equal to 25% scalp...
Once-Daily Roflumilast Cream Shows Promising for Atopic Dermatitis: JAMA Dr Riya Dave13 Feb 2025 5:45 AM ISTA 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to investigators of phase 3...
Tildrakizumab Sustains Long-Term Efficacy for Scalp Psoriasis Treatment, reveals research Dr Riya Dave1 Jan 2025 8:15 PM ISTResearchers have established that tildrakizumab, an anti-interleukin-23 p19 antibody, can be used to maintain long-term efficacy and safety for...
Deucravacitinib Found to Be Safe and Effective for Psoriasis Over 3 Years: JAMA Dr Riya Dave5 Dec 2024 8:15 PM ISTResearchers have found that deucravacitinib for long-term treatment is well tolerated and has a sustained clinical response in the management of...
Xanomeline-trospium found efficacious among schizophrenia patients experiencing acute psychosis: JAMA Dr Riya Dave2 Dec 2024 9:00 PM ISTResearchers discovered that xanomeline-trospium, a new-generation antipsychotic devoid of D2 dopamine receptor blocking activity, has shown potency...
Crisugabalin Shows Significant Pain Reduction in Postherpetic Neuralgia Patients: Study Dr Riya Dave4 Oct 2024 7:00 AM ISTResearchers found that the novel oral calcium channel subunit ligand crisugabalin significantly reduced pain in patients experiencing postherpetic...
Phentolamine Ophthalmic Solution Reverses Mydriasis Faster, suggests study Dr Riya Dave2 Oct 2024 8:15 PM ISTAccording to research, the ophthalmic solution of phentolamine 0.75% (RYZUMV), developed by Ocuphire Pharma, strongly and quickly reverses...
Tazarotene and Imiquimod Offer Similar Efficacy in Treating Plane Warts, reports study Dr Riya Dave6 May 2024 8:00 AM ISTResearchers have found that tazarotene 0.1% gel and imiquimod 5% cream offer similar efficacy in treating plane warts, according to a three-arm...
